Literature DB >> 22733575

Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.

Chee K Tan1, Alison J Carey, Xiangqin Cui, Richard I Webb, Deepak Ipe, Michael Crowley, Allan W Cripps, William H Benjamin, Kimberly B Ulett, Mark A Schembri, Glen C Ulett.   

Abstract

The most common causes of urinary tract infections (UTIs) are Gram-negative pathogens such as Escherichia coli; however, Gram-positive organisms, including Streptococcus agalactiae, or group B streptococcus (GBS), also cause UTI. In GBS infection, UTI progresses to cystitis once the bacteria colonize the bladder, but the host responses triggered in the bladder immediately following infection are largely unknown. Here, we used genome-wide expression profiling to map the bladder transcriptome of GBS UTI in mice infected transurethrally with uropathogenic GBS that was cultured from a 35-year-old women with cystitis. RNA from bladders was applied to Affymetrix Gene-1.0ST microarrays; quantitative reverse transcriptase PCR (qRT-PCR) was used to analyze selected gene responses identified in array data sets. A surprisingly small significant-gene list of 172 genes was identified at 24 h; this compared to 2,507 genes identified in a side-by-side comparison with uropathogenic E. coli (UPEC). No genes exhibited significantly altered expression at 2 h in GBS-infected mice according to arrays despite high bladder bacterial loads at this early time point. The absence of a marked early host response to GBS juxtaposed with broad-based bladder responses activated by UPEC at 2 h. Bioinformatics analyses, including integrative system-level network mapping, revealed multiple activated biological pathways in the GBS bladder transcriptome that regulate leukocyte activation, inflammation, apoptosis, and cytokine-chemokine biosynthesis. These findings define a novel, minimalistic type of bladder host response triggered by GBS UTI, which comprises collective antimicrobial pathways that differ dramatically from those activated by UPEC. Overall, this study emphasizes the unique nature of bladder immune activation mechanisms triggered by distinct uropathogens.

Entities:  

Mesh:

Year:  2012        PMID: 22733575      PMCID: PMC3418756          DOI: 10.1128/IAI.00023-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  93 in total

Review 1.  Virulence factors of uropathogens.

Authors:  Tobias A Oelschlaeger; Ulrich Dobrindt; Joerg Hacker
Journal:  Curr Opin Urol       Date:  2002-01       Impact factor: 2.309

2.  Temporal alterations in concentrations of sera cytokines/chemokines in sepsis due to group B streptococcus infection in a neonate.

Authors:  Kaoru Okazaki; Masatoshi Kondo; Masahiko Kato; Akira Nishida; Hidehiro Takahashi; Masahiro Noda; Hirokazu Kimura
Journal:  Jpn J Infect Dis       Date:  2008-09       Impact factor: 1.362

3.  Novel engagement of CD14 and multiple toll-like receptors by group B streptococci.

Authors:  P Henneke; O Takeuchi; J A van Strijp; H K Guttormsen; J A Smith; A B Schromm; T A Espevik; S Akira; V Nizet; D L Kasper; D T Golenbock
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

4.  Microarray analysis of mRNA levels from RAW264.7 macrophages infected with Brucella abortus.

Authors:  Linda Eskra; Angela Mathison; Gary Splitter
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

Review 5.  Group B streptococcal infections in elderly adults.

Authors:  Morven S Edwards; Carol J Baker
Journal:  Clin Infect Dis       Date:  2005-08-16       Impact factor: 9.079

6.  Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence.

Authors:  Manisha Yadav; Jingyao Zhang; Hans Fischer; Wen Huang; Nataliya Lutay; Christine Cirl; Josephine Lum; Thomas Miethke; Catharina Svanborg
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

7.  Evaluation of urinary IL-1alpha and IL-1beta in gravid females and patients with bacterial cystitis and microscopic hematuria.

Authors:  J V Candela; E Park; J M Gerspach; R Davidoff; L Stout; S M Levy; G E Leach; G C Bellman; P M Lad
Journal:  Urol Res       Date:  1998

8.  Diversity of group B streptococcus serotypes causing urinary tract infection in adults.

Authors:  Kimberly B Ulett; William H Benjamin; Fenglin Zhuo; Meng Xiao; Fanrong Kong; Gwendolyn L Gilbert; Mark A Schembri; Glen C Ulett
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

Review 9.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.

Authors:  Betsy Foxman
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

10.  Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease.

Authors:  Giuseppe Mancuso; Angelina Midiri; Concetta Beninati; Carmelo Biondo; Roberta Galbo; Shizuo Akira; Philipp Henneke; Douglas Golenbock; Giuseppe Teti
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  26 in total

1.  Innate immunity of surfactant proteins A and D in urinary tract infection with uropathogenic Escherichia coli.

Authors:  Fengqi Hu; Guohua Ding; Zhiyong Zhang; Louis A Gatto; Samuel Hawgood; Francis R Poulain; Robert N Cooney; Guirong Wang
Journal:  Innate Immun       Date:  2015-10-28       Impact factor: 2.680

2.  Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.

Authors:  Elizabeth S Danka; David A Hunstad
Journal:  J Infect Dis       Date:  2014-10-21       Impact factor: 5.226

3.  Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells.

Authors:  Samantha J Dando; Deepak S Ipe; Michael Batzloff; Matthew J Sullivan; David K Crossman; Michael Crowley; Emily Strong; Stephanie Kyan; Sophie Y Leclercq; Jenny A K Ekberg; James St John; Ifor R Beacham; Glen C Ulett
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

Review 4.  Lower urinary tract development and disease.

Authors:  Hila Milo Rasouly; Weining Lu
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2013-02-13

5.  Stable Expression of Modified Green Fluorescent Protein in Group B Streptococci To Enable Visualization in Experimental Systems.

Authors:  Matthew J Sullivan; Glen C Ulett
Journal:  Appl Environ Microbiol       Date:  2018-08-31       Impact factor: 4.792

Review 6.  Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract.

Authors:  Kimberly A Kline; Amanda L Lewis
Journal:  Microbiol Spectr       Date:  2016-04

7.  Urine Cytokine and Chemokine Levels Predict Urinary Tract Infection Severity Independent of Uropathogen, Urine Bacterial Burden, Host Genetics, and Host Age.

Authors:  Chelsie E Armbruster; Sara N Smith; Lona Mody; Harry L T Mobley
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

8.  Discovery and Characterization of Human-Urine Utilization by Asymptomatic-Bacteriuria-Causing Streptococcus agalactiae.

Authors:  Deepak S Ipe; Nouri L Ben Zakour; Matthew J Sullivan; Scott A Beatson; Kimberly B Ulett; William H Benjamin; Mark R Davies; Samantha J Dando; Nathan P King; Allan W Cripps; Mark A Schembri; Gordon Dougan; Glen C Ulett
Journal:  Infect Immun       Date:  2015-11-09       Impact factor: 3.441

9.  Spectrum of bacterial colonization associated with urothelial cells from patients with chronic lower urinary tract symptoms.

Authors:  Rajvinder Khasriya; Sanchutha Sathiananthamoorthy; Salim Ismail; Michael Kelsey; Mike Wilson; Jennifer L Rohn; James Malone-Lee
Journal:  J Clin Microbiol       Date:  2013-04-17       Impact factor: 5.948

10.  Group B streptococcus cystitis presenting in a diabetic patient with a massive abdominopelvic abscess: a case report.

Authors:  Kimberly B Ulett; Jennifer H Shuemaker; William H Benjamin; Chee K Tan; Glen C Ulett
Journal:  J Med Case Rep       Date:  2012-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.